Medical-Grade OEM/ODM Continuous Monitoring Hardware
Explore our certified range of screenless and smart health bracelets engineered specifically for pharmaceutical trials, early intervention, and long-term patient monitoring in Singapore and global markets.
The Paradigm Shift in Digital Biomarkers for Pharmaceutical R&D in Singapore
As Singapore cements its position as the premier biomedical and pharmaceutical research hub of the Asia-Pacific (APAC) region, the demand for medical-grade continuous vital sign monitoring has shifted from consumer-tier wellness trackers toward rigorous, regulatory-compliant OEM digital biomarker platforms. Pharmaceutical sponsors, Contract Research Organizations (CROs), and clinical trial leaders operating out of locations such as Biopolis and Tuas Biomedical Park require uncompromised raw physiological data to validate novel therapies.
Traditional clinical trial methodologies rely on intermittent, in-clinic "spot-check" measurements. These episodic observations frequently fail to capture transient events, nighttime autonomic fluctuations, or early micro-signals of adverse drug reactions (ADRs). By integrating custom OEM screenless biosensors—such as the CardioWatch 287 framework—sponsors can capture continuous raw photoplethysmography (PPG), single-lead electrocardiography (ECG), galvanic skin response (GSR), skin temperature, and tri-axial acceleration.
Our dedicated OEM/ODM manufacturing facility operates strictly under ISO 13485 Quality Management Systems. Designed from the ground up to support CE-MDR and FDA 510(k) clearance pathways, our digital biomarker devices bridge the gap between patient comfort and clinical precision.
Through open REST APIs and mobile SDKs, biomedical engineers and data scientists in Singapore can extract high-fidelity uncompressed raw signal streams at sampling frequencies up to 128 Hz. This empowers research teams to construct proprietary algorithms, validate targeted digital biomarkers, and streamline Decentralized Clinical Trials (DCTs) without hardware vendor lock-in or IP restrictions.
End-to-End Customization for Life Science Sponsors
From full white-label hardware engineering to raw sensor data pipelines, discover why leading pharmaceutical manufacturers partner with us in Singapore.
Unrestricted Raw Data Sampling
Access unfiltered PPG (Green, Red, Infrared wavelengths), single-lead ECG rhythm strips, continuous skin temperature, and raw 3-axis accelerometer data up to 128 Hz for advanced AI model training.
Regulatory Certification Ready
Built under ISO 13485 standards and aligned with CE-MDR Class IIa and FDA 510(k) medical device directives, drastically accelerating HSA (Health Sciences Authority) registration timelines in Singapore.
Custom Firmware & SDK Integration
Seamlessly integrate real-time physiological telemetry into hospital EMR systems (Epic, Cerner), customized mobile trial apps, and centralized eCOA platforms via HL7 FHIR protocols.
Screenless High-Compliance Design
Screenless form factors remove patient distraction, reduce cognitive burden, prevent parameter manipulation during trials, and extend operational battery life up to 15 continuous days.
Multi-Parameter EWS Computation
Real-time edge computation of Early Warning Scores (EWS), detecting physiological decline, sepsis, respiratory distress, and cardiovascular events hours prior to physical symptoms.
Full IP Ownership & White-Labeling
We provide comprehensive OEM hardware customization—including enclosure branding, specialized sensor configurations, custom packaging, and IP-free firmware architecture.
Tailored Application Scenarios across Singapore's Healthcare Ecosystem
Enabling continuous monitoring across public health clusters, academic medical institutions, and regional clinical trial hubs.
1. Decentralized Clinical Trials (DCTs) in APAC Hubs
Singapore acts as the central coordinator for multi-center clinical trials across Southeast Asia. Custom OEM screenless wearables enable CROs to collect synchronized biometric telemetry from trial subjects living anywhere in Singapore or neighboring regions, maintaining continuous oversight without requiring frequent hospital visits.
2. SingHealth & NHG General Ward Early Warning
Integrating continuous monitoring devices into general wards at major medical centers (e.g., Singapore General Hospital, Tan Tock Seng Hospital, National University Hospital) closes the critical baseline observation gap between 4-to-6-hour manual nursing rounds, automatically computing early warning scores to detect deterioration.
3. Post-Discharge & Hospital-at-Home (MIC@Home)
Aligning with Singapore’s Ministry of Health (MOH) Mobile Inpatient Care@Home (MIC@Home) initiatives, our cellular-enabled (4G/LTE-M) OEM smart bands ensure that high-risk cardiac, oncology, or respiratory patients transition smoothly from acute ward beds to home recovery with uninterrupted telemetry.
4. Digital Therapeutics (DTx) & Biomarker Validation
Biotech startups and research institutions within Singapore's Biopolis leverage our IP-free raw data streaming platforms to discover novel disease endpoints, validate software-as-a-medical-device (SaMD) algorithms, and execute continuous stress and sleep biomarker research.
Why Consumer Wearables Fail in Pharmaceutical Clinical Trials
A technical comparison highlighting the essential requirements for regulatory-grade digital biomarker capture.
| Evaluation Parameter | Standard Consumer Fitness Bands | Our OEM Pharmaceutical Digital Biomarker Platform |
|---|---|---|
| Raw Data Access | Proprietary algorithms; black-box aggregated metrics; no access to raw signals. | Full IP-free raw signal access (PPG G/R/iR, ECG, Accelerometer, Temp, GSR) up to 128 Hz. |
| Regulatory Auditing | Non-medical grade; non-compliant with medical trial endpoint requirements. | Manufactured under ISO 13485; CE-MDR certified & FDA 510(k) cleared architecture. |
| Data Privacy & Compliance | Cloud data stored on commercial servers; potential GDPR/PDPA friction. | Strict alignment with Singapore PDPA, HIPAA, and GDPR; localized server deployment options. |
| Patient Compliance | Screen notifications distract patients; user intervention required. | Screenless, single-purpose, "wear-and-forget" design optimizing long-term compliance. |
| System Interoperability | Closed vendor ecosystem; difficult third-party software integration. | Open REST APIs, native iOS/Android SDKs, and HL7 FHIR EMR integration. |
| White-Label Customization | Fixed consumer branding; impossible to modify hardware or packaging. | Comprehensive OEM/ODM customization of firmware, housing, sensors, and app portals. |
Local Market Dynamics & HealthTech Trends in Singapore (2025–2030)
Smart Nation 2030 & Preventive Health
Singapore’s Healthier SG initiative emphasizes proactive, continuous health risk monitoring. Pharmaceutical companies are partnering with OEM device manufacturers to bundle remote biomarker monitoring with targeted chronic disease management programs.
Expansion of Decoupled Clinical Research
With major regional CROs establishing headquarters in Singapore, decentralized trial designs have become standard. Multi-sensor wearable platforms with global connectivity (4G LTE-M / NB-IoT) bridge geographical barriers across APAC studies.
AI-Driven Biomarker Extraction
Local research institutions are investing heavily in machine learning algorithms that analyze multi-spectral PPG signals to detect non-invasive continuous blood pressure, arterial stiffness, and early sepsis indicators.
Frequently Asked Questions by Singapore Procurement & R&D Teams
Accelerate Your Clinical Trial & RPM Deployment in Singapore
Speak with our senior biomedical engineers and technical project leads today. Request customized hardware samples, technical API documentation, or a tailored OEM quotation.
Contact Us